Wearing a face mask is a common sight in Korea during the COVID-19 outbreak. Due to the overwhelming demand, last week the government started to ration two masks per person per week, as a drastic measure to address the supply fiasco.
The face masks most commonly used are disposable ones, originally made for filtering out up to 94 or 95 percent of fine dust, referred to as N94 or N95 masks.
A KAIST research team announced that they have developed a nano-filter that maintains excellent filtering efficiency even after hand washing through the development of proprietary technology that aligns nanofibers with a diameter of 100~500 nm in orthogonal or unidirectional directions. This reusable nano-filtered face mask could help to relieve the challenges arising from the supply shortage of face masks.
Professor Il-Doo Kim’s nano-fiber filtered mask will maintain its sturdy frame and filtering function even after being washed more than 20 times. Professor Kim, who has continued to study the filtering of fine dust using nano-filters, is now awaiting final approval from the Ministry of Food and Drug Safety to bring his product into the market.
Professor Kim used an insulation block electrospinning process to manufacture orthogonal nanofibers by controlling the alignment of nanofibers. This structure can minimize delivering of the pressure toward the air filter and maximize the filtration efficiency, which is different from existing disposable masks without nano-fibers.
Existing masks also fail to maintain their air filtering function because their electrostatic function disappears when exposed to water. Thus, their filtering efficiency is reduced significantly, making it almost impossible to reuse them. However, this nano-fiber design was proven to be water resistant with more than 94% filtering efficiency in 20 repeated bactericidal tests with ethanol. The nano-fiber mask also showed no deformation in its nano-membrane structure despite the 20 hand washes. In particular, it was confirmed that there were no deformations in the membrane, even after soaking in ethanol more than three hours.
Professor Kim said, “We believe that this mask can be reusable for about a month even after washing in ethanol. The inner filter can also be replaced.” He added, “We found that the mask filters out up to 80 percent of 600-nanometer particles even after undergoing a bending test more than 4,000 times.”
Professor Kim established his startup company, the “Kim Il-Doo Research Institute,” last February. It can currently produce 1,500 nano-fiber filters per day.
< Professor Kim and his researcher demonstrate recyclable nano-fiber filter for mask. >
Professor Il-Doo Kim from the Department of Materials Science and Engineering received the Science and ICT Minister’s Award in recognition of his commercialization and technology transfer achievements during the Day of IP celebration. Professor Kim, who has made over 222 patents application and registration home and abroad, has advanced toxic gas detection and breath gas sensor technology by arraying nanosensor fibers. His technological advances in micro-electro-mechanical systems (MEMS2021-09-15
The Mobile Clinic Module (MCM) developed by the KAIST Action for Respiratory Epidemics was installed at special residential treatment center in Gyeonggi Province on September 13. The MCM is an isolate negative pressure unit fitted with high-quality medical equipment, developed by Professor Taek-Jin Nam of the Department of Industrial Design under the KAIST New Deal R&D Initiative. This is also a part of the Korean Disease Control Package Development Project from last July. In January, a2021-09-15
A longitudinal study of macrophages from SARS-CoV-2 infected lungs offers new insights into dynamic immunological changes A KAIST immunology research team found that a specific subtype of macrophages that originated from blood monocytes plays a key role in the hyper-inflammatory response in SARS-CoV-2 infected lungs, by performing single-cell RNA sequencing of bronchoalveolar lavage fluid cells. This study provides new insights for understanding dynamic changes in immune responses to COVID-12021-08-04
Virtual screening of 6,218 drugs and cell-based assays identifies best therapeutic medication candidates A joint research group from KAIST and Institut Pasteur Korea has identified repurposed drugs for COVID-19 treatment through virtual screening and cell-based assays. The research team suggested the strategy for virtual screening with greatly reduced false positives by incorporating pre-docking filtering based on shape similarity and post-docking filtering based on interaction similarity. Th2021-07-08
Researchers confirm that most COVID-19 patients in their convalescent stage carry stem cell-like memory T cells for months A KAIST immunology research team found that most convalescent patients of COVID-19 develop and maintain T cell memory for over 10 months regardless of the severity of their symptoms. In addition, memory T cells proliferate rapidly after encountering their cognate antigen and accomplish their multifunctional roles. This study provides new insights for effective vaccine str2021-07-05